ChemAesthetic | For research use only
60 x 10mg capsules
βΈ»
π¬ Compound Overview
SR9009, also known as Stenabolic, is a REV-ERBΞ± agonist investigated in research models for its effects on circadian rhythm regulation, metabolic activity, and mitochondrial function.
In preclinical studies, SR9009 has been explored for its potential to:
β’ Enhance mitochondrial activity and metabolic output
β’ Support endurance-related performance models
β’ Regulate lipid and glucose metabolism
β’ Influence fat oxidation and wake-sleep cycles
Often referred to in literature as an βexercise mimetic,β SR9009 is studied in models simulating increased energy expenditure without physical training.
βΈ»
π Dosing Protocols (For Research Use Only)
β’ Common research dosage: 20mg to 30mg per day
β’ Frequency: Split into 2β3 doses daily due to short half-life
β’ Duration: 4β8 weeks in metabolic, endurance, or recomposition models
β’ Administered orally
Researchers often monitor circadian timing, activity levels, and metabolic markers during SR9009 protocols.
βΈ»
β οΈ Legal & Research Disclaimer
β’ Supplied strictly for laboratory research purposes only
β’ Not for human or veterinary use
π Research Protocol Pages
Select a compound to view detailed protocol and study information: